Dr. Michael Rezak, MD, Ph.D., DBe, is a renowned neurologist specializing in the treatment of complex movement disorders such as Parkinson's Disease, ...
1don MSN
For the first time, students in Israel will be able to study OT in a program tailored for new olim. DR. NAOMI FERZIGER, ...
6don MSN
Sneak peek at San Diego community events street fairs, festivals, concerts, performances, art shows, community meetings ...
Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state
In patients with Parkinson’s disease and in animal models of this disorder, neurons in the basal ganglia and related regions in thalamus and cortex show changes that can be recorded by using ...
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...
Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback